Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 (Kd: 136 pM). Tildrakizumab is effective against moderate to severe plaque psoriasis.
Tiliroside is a glycoside flavonoid with antidiabetic properties. Tiliroside is a noncompetitive inhibitor of α-amylase with a Ki value of 84.2 μM. Tiliroside inhibits carbohydrate digestion and glucose absorption in the gastrointestinal tract.
Tiliroside is a glycoside flavonoid with antidiabetic properties. Tiliroside is a noncompetitive inhibitor of α-amylase with a Ki value of 84.2 μM. Tiliroside inhibits carbohydrate digestion and glucose absorption in the gastrointestinal tract.
Tiliroside is a glycoside flavonoid with antidiabetic properties. Tiliroside is a noncompetitive inhibitor of α-amylase with a Ki value of 84.2 μM. Tiliroside inhibits carbohydrate digestion and glucose absorption in the gastrointestinal tract.
Tilmicosin phosphate is a antibiotic, is used in veterinary medicine for the treatment of bovine respiratory disease and ovine respiratory disease associated with Mannheimia (Pasteurella) haemolytica.
Tilorone dihydrochloride is an orally active interferon inducer, used as an antiviral compound.
Timentin has a wide range of antibacterial activity against gram-positive, negative, aerobic and anaerobic bacteria. The components are Ticarcillin Sodium and Clavulanate Potassium, with an effective acid ratio of 15:1.